查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1645710

全球同位素市场（按类型和应用）- 机会分析和产业预测，2024 年至 2033 年

Isotopes Market By Type (Stable, Unstable), By Application (Medical, Industrial, Agricultural, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 259 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球同位素市场价值为 113 亿美元，预计 2033 年将达到 258 亿美元，2024 年至 2033 年的复合年增长率为 8.7%。

同位素分为稳定同位素和放射性同位素（不稳定）。稳定同位素不会随时间而变化，也不具有放射性，但放射性同位素（放射性核种）会随时间而崩坏变成其他元素，并在此过程中释放辐射。同位素的稳定性和放射性影响医学、工业和研究等各领域的应用。放射性同位素用于多种诊断成像技术。例如，Technetium-99m具有理想的成像特性，包括较短的半衰期和它发射的伽马射线，因此它被广泛用于单光子发射电脑断层扫描（SPECT）。这种同位素可以使器官、骨骼和其他组织可见，并有助于诊断癌症、心臟病、骨骼疾病等。

同位素市场-IMG1

放射性同位素在治疗中发挥重要作用。例如，碘-131用于治疗甲状腺癌和甲状腺功能亢进。这种同位素针对甲状腺细胞并发出辐射，破坏癌细胞并减缓甲状腺功能亢进。同样，锶-89和钐-153可透过针对骨病变来治疗与转移性癌症相关的骨痛。在癌症治疗中，钴-60等放射性同位素用于外部放射治疗。钴-60发射的伽马射线可以穿透人体并杀死癌细胞，同时最大限度地减少对周围健康组织的伤害。

在工业X射线摄影中，铱-192和钴-60等同位素用于检查结构和零件的完整性。这些同位素会发射伽马射线，能够穿透材料。所得到的图像可以揭示裂缝和腐蚀等内部缺陷，对于确保管道和焊接等结构的安全性和可靠性至关重要。同位素在工业製程的研究中扮演示踪剂的角色。例如，碳-14和氘（氢的稳定同位素）用于追踪化学反应和过程，使科学家能够研究反应机制、流动模式和物质分布。这有助于优化石化和製药等行业的流程。

同位素对于研究水源和迁移很有用。例如，氚（氢的放射性同位素）可用于追踪地下水运动并评估水的年龄。氢和氧的稳定同位素也用于分析水体的来源和路径，这对于水资源管理和污染调查很有用。碳-13和氮-15等稳定同位素用于研究生物系统中的代谢过程、食物网和营养循环。同位素标记有助于追踪元素在生物体和生态系统中的运动，提供有关生物功能和相互作用的宝贵资讯。

同位素市场分为类型、最终用途产业和地区。根据类型，市场分为稳定市场和波动市场。根据应用，市场分为医疗、工业、农业和其他。根据地区，市场分为北美、欧洲、亚太、拉丁美洲和中东及非洲。

按类型划分，不稳定同位素成长最快，预测期内复合年增长率为 9.0%。不稳定同位素，又称为放射性同位素或放射性同位素，儘管本身俱有不稳定性，但在许多行业中却有着多样化且重要的应用。在医学上，不稳定同位素对于诊断影像和治疗至关重要。例如，Technetium-99m是一种伽马射线发射同位素，由于其能够突出显示生理过程，被广泛用于核医学的骨骼、器官和组织的诊断成像。放射性碘（I-131）还可以选择性地靶向甲状腺细胞，因此被广泛用于治疗甲状腺疾病，包括甲状腺功能亢进和某些类型的癌症。此外，氟-18等正子发射同位素可用于正子断层扫描 (PET) 扫描，以观察组织中的代谢活动，有助于癌症等疾病的早期诊断。

从地区来看，亚太地区占据市场主导地位，预测期内成长最快，复合年增长率为 9.0%。在亚太地区，同位素广泛应用于各种应用、产品和产业，对医疗、工业、农业和环境部门产生重大影响。在医学领域，Technetium-99m等同位素在日本、韩国、中国等国家被广泛应用于诊断影像和癌症治疗。放射治疗、核子医学摄影和 PET 扫描是受益于这些同位素的基本医疗服务，有助于高精度地识别、监测和治疗病情。碘-131和钴-60是癌症治疗和放射疗法中常用的其他同位素，使亚太地区的医院和医疗中心能够提供更先进的医疗干预。

预计预测期内核医学技术的创新将推动同位素市场的成长。核子医学的进步透过放射性药物和成像技术的创新刺激了对专用同位素的需求。在该领域，放射性同位素用于诊断和治疗疾病，PET、SPECT等影像诊断方法是关键。最近的趋势导致了更有效的放射性药物的开发。 2022 年 2 月，核子医学和分子影像学会 (SNMMI) 发起了倡议，将核子医学设施认定为放射性药物治疗卓越中心 (COE)。该计划对法规遵从性、员工培训、资格和绩效设定了高标准，以确保接受放射性药物治疗的患者获得最佳结果。

预计预测期内原料供应有限将成长抑制因素。同位素生产所需原料的可用性是同位素市场的一个主要限制因素。许多同位素是由稀有或低丰度原料生产的，而这些原料的供应可能有限。这种稀缺性可能导致生产同位素和使用它们的最终产品的成本更高。例如，医学影像和工业应用中使用的某些同位素来自于不广泛存在的特定元素或矿物。

相关人员的主要利益

  • 本报告定量分析了市场区隔、当前趋势、估计和趋势分析、2023 年至 2033 年同位素市场分析的动态，并确定了同位素市场的突出机会。
  • 它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。
  • 波特五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的商业决策，并加强供应商-买家网络。
  • 对同位素市场细分的详细分析有助于确定市场机会。
  • 每个地区的主要国家都根据收益贡献进行划分。
  • 市场公司的定位有利于进行对标，并能清楚了解市场公司的当前地位。
  • 报告包括区域和全球同位素半导体市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化（需支付额外费用和时间表）

  • 产品成分分析（%）
  • 最终用户的偏好和痛点
  • 投资机会
  • 新参与企业（按地区）
  • 科技趋势分析
  • 按产品/细分市场对参与者进行市场区隔分析
  • 主要公司的新产品开发/产品矩阵
  • 国家、地区和全球层面的患者/流行病学资料
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 历史市场资料
  • Excel 格式的主要企业详细资料（包括位置、联络资讯、供应商/供应商网路等）
  • 客户/消费者/原料供应商名单－价值链分析
  • SWOT 分析
  • 量化市场规模及预测

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 关键影响因素
    • 重大投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 核子医学技术创新
      • 工业 X 射线成像需求不断成长
    • 限制因素
      • 同位素生产成本上升
    • 机会
      • 诊断影像需求不断成长
  • 专利分析

第 4 章 同位素市场类型

  • 概述
  • 稳定
  • 不稳定

第 5 章 同位素市场（依应用）

  • 概述
  • 医疗的
  • 工业的
  • 农业
  • 其他的

6. 同位素市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 南非
    • 沙乌地阿拉伯
    • 其他的

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品图谱
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第八章 公司简介

  • 3M
  • Isotope JSC
  • Cambridge Isotope Laboratories, Inc.
  • Center of Molecular Research（CMR）
  • Urenco
  • Linde PLC
  • Marshall Isotopes Ltd.
  • Eckert & Ziegler
  • Laurentis Energy Partners Inc.
  • Nordion（Canada）Inc.
简介目录
Product Code: A123022

The global isotopes market was valued at $11.3 billion in 2023, and is projected to reach $25.8 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Isotopes can be classified into stable and radioactive (unstable) isotopes. Stable isotopes do not change over time and are not radioactive, while radioactive isotopes, or radionuclides, decay over time into other elements, emitting radiation in the process. The stability or radioactivity of an isotope influences its application in various fields, including medicine, industry, and research. Radioactive isotopes are used in various imaging techniques. For instance, Technetium-99m is widely used in single photon emission computed tomography (SPECT) scans due to its ideal properties for imaging, such as its short half-life and the gamma rays it emits. This isotope helps in visualizing organs, bones, and other tissues, aiding in the diagnosis of conditions like cancer, heart disease, and bone disorders.

Isotopes Market - IMG1

Radioisotopes play a important role in the medical treatment. For instance, Iodine-131 is used in the treatment of thyroid cancer and hyperthyroidism. This isotope targets thyroid cells and emits radiation to destroy cancerous cells or reduce the function of an overactive thyroid. Similarly, strontium-89 and samarium-153 are used to treat bone pain associated with metastatic cancer by targeting bone lesions. In cancer treatment, radioactive isotopes such as cobalt-60 are used in external beam radiotherapy. Cobalt-60 emits gamma rays that can penetrate the body and kill cancer cells, while minimizing damage to surrounding healthy tissue.

In industrial radiography, isotopes like iridium-192 and cobalt-60 are used to inspect the integrity of structures and components. These isotopes emit gamma rays that pass through materials, and the resulting images reveal internal flaws such as cracks or corrosion, which are crucial for ensuring the safety and reliability of structures like pipelines and welds. Isotopes serve as tracers in studies of industrial processes. For instance, Carbon-14 and deuterium (a stable isotope of hydrogen) are used to trace chemical reactions and processes, allowing scientists to study reaction mechanisms, flow patterns, and material distribution. This helps optimize processes in industries such as petrochemicals and pharmaceuticals.

Isotopes help in studying water sources and movement. For example, tritium (a radioactive isotope of hydrogen) is used to trace groundwater movement and assess water age. Stable isotopes of hydrogen and oxygen are also used to analyze the origins and pathways of water bodies, aiding in water resource management and pollution studies. Stable isotopes such as carbon-13 and nitrogen-15 are used to study metabolic processes, food webs, and nutrient cycling in biological systems. Isotopic labeling helps trace the movement of elements through organisms and ecosystems, providing valuable information on biological functions and interactions

The isotopes market is segmented into type, end-use industry, and region. On the basis of type, the market is classified into stable and unstable. On the basis of application, the market is classified into medical, industrial, agricultural, and others. Based on region the market is divided into North America, Europe, Asia-Pacific, and LAMEA.

On the basis of type, unstable is the fastest-growing segment in the market representing the CAGR of 9.0% during the forecast period. Unstable isotopes, also known as radioactive isotopes or radioisotopes, have diverse and critical applications across numerous industries, despite their inherent instability. In the medical field, unstable isotopes are essential for diagnostic imaging and treatment. For example, technetium-99m, a gamma-emitting isotope, is widely used in nuclear medicine for imaging bones, organs, and tissues due to its ability to highlight physiological processes. Radioactive iodine (I-131) is also extensively used to treat thyroid conditions, including hyperthyroidism and certain types of cancer, as it can selectively target thyroid cells. Additionally, positron-emitting isotopes like fluorine-18 are used in positron emission tomography (PET) scans to visualize metabolic activity in tissues, aiding in early diagnosis of diseases such as cancer.

Based on region Asia-Pacific dominated and fastest growing segment in the market representing the CAGR of 9.0% during the forecast period. In the Asia-Pacific region, isotopes are widely used across various applications, products, and industries, significantly impacting medical, industrial, agricultural, and environmental sectors. In the medical field, isotopes like Technetium-99m are heavily utilized for diagnostic imaging and cancer treatment in countries such as Japan, South Korea, and China. Radiotherapy, nuclear imaging, and PET scans are critical healthcare services that benefit from these isotopes, helping identify, monitor, and treat conditions with high precision. Iodine-131 and Cobalt-60 are other common isotopes used in cancer treatments and radiotherapy, enabling hospitals and medical centers across Asia-Pacific to offer more advanced medical interventions.

Innovations in nuclear medicine technologies are expected to drive the growth of the isotopes market during the forecast period. Advancements in nuclear medicine have spurred demand for specialized isotopes due to innovations in radiopharmaceuticals and imaging technologies. This field uses radioactive isotopes for diagnosing and treating diseases, with imaging methods like PET and SPECT being key. Recent breakthroughs have led to the development of more effective radiopharmaceuticals. In February 2022, the society of nuclear medicine and molecular Imaging (SNMMI) launched an initiative to certify nuclear medicine facilities as Centers of Excellence in Radiopharmaceutical Therapy. This program sets high standards for regulatory compliance, staff training, qualifications, and performance to ensure the best outcomes for patients undergoing radiopharmaceutical therapy.

Limited availability of raw materials is expected to restraint the growth of the isotopes market during the forecast period. The availability of raw materials required for isotope production is a significant constraint in the isotopes market. Many isotopes are produced from rare or less abundant materials, and the supply of these raw materials can be limited. This scarcity can lead to increased costs for both the production of isotopes and the end products that utilize them. For example, certain isotopes used in medical imaging or industrial applications are derived from specific elements or minerals that are not widely distributed.

The key players operating in the isotopes market include 3M, Isotope JSC, Cambridge Isotope Laboratories, Inc, Center of Molecular Research (CMR), Urenco, National High Technology Centre of Georgia, Linde plc, Marshall Isotopes Ltd, Eckert & Ziegler, and Laurentis Energy Partners Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the isotopes market analysis from 2023 to 2033 to identify the prevailing isotopes market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the isotopes market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global isotopes market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Analysis of raw material in a product (by %)
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • List of customers/consumers/raw material suppliers- value chain analysis
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Type

  • Stable
  • Unstable

By Application

  • Others
  • Medical
  • Industrial
  • Agricultural

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • 3M
    • Cambridge Isotope Laboratories, Inc.
    • Center of Molecular Research (CMR)
    • Eckert & Ziegler
    • Isotope JSC
    • Laurentis Energy Partners Inc.
    • Linde PLC
    • Marshall Isotopes Ltd.
    • Nordion (Canada) Inc.
    • Urenco

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderatre threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Innovations in nuclear medicine technologies
      • 3.4.1.2. Increase in demand for industrial radiography
    • 3.4.2. Restraints
      • 3.4.2.1. High production costs of isotopes
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in demand for diagnostic imaging
  • 3.5. Patent Analysis

CHAPTER 4: ISOTOPES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Stable
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Unstable
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ISOTOPES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Medical
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Industrial
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Agricultural
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ISOTOPES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. India
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. South Africa
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. Saudi Arabia
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. 3M
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. Isotope JSC
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
  • 8.3. Cambridge Isotope Laboratories, Inc.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
  • 8.4. Center of Molecular Research (CMR)
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
  • 8.5. Urenco
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Linde PLC
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
  • 8.7. Marshall Isotopes Ltd.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Eckert & Ziegler
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Laurentis Energy Partners Inc.
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
  • 8.10. Nordion (Canada) Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio